Investors Encouraged to Join Class Action Against Hims & Hers Health, Inc.
On July 15, 2025, Levi & Korsinsky, LLP announced the initiation of a class action securities lawsuit targeting investors of Hims & Hers Health, Inc. The lawsuit aims to represent those who incurred losses due to alleged fraudulent activities involving the company's stock within the specified period from April 29, 2025, to June 23, 2025.
The lawsuit seeks to recover losses for investors adversely affected by what has been described as securities fraud. Investors are invited to obtain further information and potentially participate in the lawsuit. Interested parties can connect with Levi & Korsinsky through their website to fill out a submission form or contact them directly via email or phone.
The filed complaint indicates that the defendants allegedly made misleading statements regarding Hims & Hers Health, Inc. It is reported that the defendants were involved in the promotion and selling of dishonorable, imitation versions of Wegovy®, which posed significant risks to patient safety. The complaint further alleges that these actions led to a considerable risk of Hims losing its collaboration with Novo Nordisk, thereby jeopardizing the company's overall operational stability and future prospects. Investors are cautioned that the positive public statements made about the company during this period were misleading and lacked a sound basis in truth.
Investors who have experienced losses due to the trading of Hims & Hers Health, Inc. shares during the relevant timeframe have until August 25, 2025, to apply to be appointed as lead plaintiff in this class action. It’s crucial to note that participation in the case as a class member does not necessitate serving as a lead plaintiff.
This class action allows investors to seek compensation without incurring any out-of-pocket costs. Participation comes without any fees or obligations, making it accessible for all affected investors.
Levi & Korsinsky has a proven track record, having secured hundreds of millions of dollars for shareholders over the past two decades. The firm has focused on representing clients in complex securities litigation and has garnered a reputation of excellence, being consistently ranked among the top securities litigation firms in the United States by ISS Securities Class Action Services for seven consecutive years.
For more details on this class action or to learn about your rights as an investor in Hims & Hers Health, Inc., please reach out to Levi & Korsinsky at:
This class action offers a chance for justice and reparation for those who have been negatively impacted by the alleged misleading tactics of Hims & Hers Health, Inc.
Class Action Overview
The lawsuit seeks to recover losses for investors adversely affected by what has been described as securities fraud. Investors are invited to obtain further information and potentially participate in the lawsuit. Interested parties can connect with Levi & Korsinsky through their website to fill out a submission form or contact them directly via email or phone.
Case Details
The filed complaint indicates that the defendants allegedly made misleading statements regarding Hims & Hers Health, Inc. It is reported that the defendants were involved in the promotion and selling of dishonorable, imitation versions of Wegovy®, which posed significant risks to patient safety. The complaint further alleges that these actions led to a considerable risk of Hims losing its collaboration with Novo Nordisk, thereby jeopardizing the company's overall operational stability and future prospects. Investors are cautioned that the positive public statements made about the company during this period were misleading and lacked a sound basis in truth.
Next Steps for Investors
Investors who have experienced losses due to the trading of Hims & Hers Health, Inc. shares during the relevant timeframe have until August 25, 2025, to apply to be appointed as lead plaintiff in this class action. It’s crucial to note that participation in the case as a class member does not necessitate serving as a lead plaintiff.
No Financial Obligation
This class action allows investors to seek compensation without incurring any out-of-pocket costs. Participation comes without any fees or obligations, making it accessible for all affected investors.
Why Choose Levi & Korsinsky?
Levi & Korsinsky has a proven track record, having secured hundreds of millions of dollars for shareholders over the past two decades. The firm has focused on representing clients in complex securities litigation and has garnered a reputation of excellence, being consistently ranked among the top securities litigation firms in the United States by ISS Securities Class Action Services for seven consecutive years.
Contact Information
For more details on this class action or to learn about your rights as an investor in Hims & Hers Health, Inc., please reach out to Levi & Korsinsky at:
- - Address: 33 Whitehall Street, 17th Floor, New York, NY 10004
- - Email: email protected]
- - Phone: (212) 363-7500
- - Website: [www.zlk.com
This class action offers a chance for justice and reparation for those who have been negatively impacted by the alleged misleading tactics of Hims & Hers Health, Inc.
Topics Financial Services & Investing）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.